arrow_back Back to App

Mandatory Medicaid Coverage for Lung Cancer Biomarker Testing.

This law mandates that the Medicaid program must cover the costs of advanced lung cancer biomarker testing. This ensures that individuals relying on Medicaid gain access to precise diagnostic tools, potentially improving early detection and treatment outcomes for lung cancer. These changes will take effect starting January 1, 2027.
Key points
Medicaid is required to cover lung cancer biomarker testing.
The change expands access to advanced diagnostic services for Medicaid recipients.
The new coverage requirements become effective on January 1, 2027.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6320
Sponsor: Rep. Gottheimer, Josh [D-NJ-5]